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measurement was the upper-limb part of the Fugl-Meyer As-
sessment (FMA).  Results:  The ARMin training was well toler-
ated by the patients, and the FMA showed moderate, but 
significant improvements for all 3 subjects (p  ! 0.05). Most 
improvements were maintained 8 weeks after discharge. 
 Conclusions: This study indicates that intensive training 
with an arm exoskeleton is feasible with chronic-stroke pa-
tients. Moderate improvements were found in all 3 subjects, 
thus further clinical investigations are justified. 
 Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 In Western countries, stroke is the leading cause of 
disability. Recent studies estimate that stroke affects 
more than 700,000 individuals in the US alone each year 
 [1] . One major symptom of stroke is acute motor and sen-
sory hemiparesis that affects the upper extremities  [2] . 
Several studies show that sensorimotor arm therapy has 
positive effects on the rehabilitation progress of stroke 
patients  [3] .The critical factors are that the therapy is  in-
tensive  [4–6] , of  long duration  [7] ,  repetitive,  [8] and  task-
oriented  [9–12] .
 Key Words 
 Stroke   Rehabilitation   Recovery of function   Upper 
extremity   Robotics 
 Abstract 
 Background:  Several clinical studies on chronic stroke con-
ducted with end-effector-based robots showed improve-
ment of the motor function in the affected arm. Compared 
to end-effector-based robots, exoskeleton robots provide 
improved guidance of the human limb and are better suited 
to train task-oriented movements with a large range of mo-
tions.  Objective: To test whether intensive arm training with 
the arm exoskeleton ARMin I is feasible with chronic-stroke 
patients and whether it improves motor function in the pa-
retic arm.  Methods: Three single cases with chronic hemipa-
resis resulting from unilateral stroke (at least 14 months after 
stroke). A-B design with 2 weeks of multiple baseline mea-
surements (A), 8 weeks of training (B) with repetitive mea-
surements and a follow-up measurement 8 weeks after 
training. The training included shoulder and elbow move-
ments with the robotic rehabilitation device ARMin I. Two 
subjects had three 1-hour sessions per week and 1 subject 
received five 1-hour sessions per week. The main outcome 
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 Regarding these criteria, one-to-one manually assist-
ed training has important limitations. The training is
labor-intensive and, therefore, expensive. As a conse-
quence, the rehabilitation period and single training ses-
sions are often shorter than required to achieve maxi-
mum therapeutic outcomes. Moreover, manually assisted 
training lacks repeatability and objective measures of pa-
tient performance and progress.
 Some shortcomings can be overcome with robots that 
automate part of the training sessions and allow increas-
ing the number and duration of the training sessions. 
Furthermore, so-called patient-cooperative control strat-
egies allow patient-driven movements supported by the 
robot only as much as needed  [13] . These control strate-
gies are combined with game-like graphical training sce-
narios to maximize the patient’s motivation and the 
training intensity  [14] . While all existing therapy robots 
[see ref.  15, 17, 25 for reviews] allow repetitive training, 
state-of-the-art actuated robots cannot support  task-ori-
ented training of activities of daily living (ADL). One rea-
son for this limitation is that these robots do not provide 
the number of actuated joints and the range of motion 
(ROM) that is required for most ADL tasks. Activities 
like eating, drinking and dressing require robots with 
many actuated joints and with a large ROM  [18] . Anoth-
er reason is that we do not know how much patients will 
gain from multijoint ADL training compared to other 
training paradigms  [19] . 
 Most existing arm therapy robots are so-called end-
effector-based robots ( fig. 1 ), where the human hand or 
lower arm is connected to the end effector of the robot. 
Examples of end-effector-based robots are the MIT-MA-
NUS robot  [20] , the MIME robot  [21] and the ACT-3D 
robot  [22] . These devices support hand positioning in the 
3D space. Since only one segment of the human limb is 
connected to the robot (i.e. the hand or the lower arm), 
the individual joint torques are not independently con-
trollable by the robot. 
 With respect to this shortcoming, several groups have 
begun working with exoskeleton robots. Examples are 
the MGA exoskeleton  [23] , CADEN-7  [24] , and the L-
Exos  [25] . The mechanical structure of exoskeleton ro-
bots resembles the human arm anatomy, and the robot’s 
rotation axes correspond to those of the human arm 
( fig. 1 ). Consequently, the human arm can be attached to 
the exoskeleton at several points. Adaptation to different 
body sizes is, therefore, more difficult than with end-ef-
fector-based systems since each robot link must be ad-
justed to the length of the patient’s arm segment. How-
ever, the advantage of exoskeleton robots compared to 
end-effector-based ones is that the arm posture is fully 
determined and the torques applied to each joint of the 
human arm can be controlled separately. The ability to 
control the interacting torques separately in each joint is 
essential, notably when the subject’s elbow flexors are 
spastic. Consequently, exoskeleton robots are able to sup-
port movements with larger ROM, and, therefore, these 
robots are generally better suited for ADL tasks. 
 Several clinical studies have been conducted with end-
effector-based robots and they show good results in 
chronic and subacute stroke [see ref.  26 for a review]. 
However, no clinical results from studies with active exo-
skeleton robots have been reported yet. This paper at-
tempts to address this issue. The underlying hypothesis 
is that the effects of functional,  task-oriented training
 [9–12] are superior to the training of nonfunctional arti-
ficial movements. Therefore, we hypothesize that the out-
come of ADL-oriented training with exoskeleton robots 
will be superior to the outcome of state-of-the-art end-ef-
fector-based robots.
 This hypothesis is supported by encouraging results 
from clinical studies with passive (nonmotorized), non-
robotic exoskeletons. One such device, T-WREX  [27] , is 
an instrumented exoskeleton that is equipped with 
springs and allows the training of ADL tasks in a gravity-
reduced environment. Sensors measure the actual posi-
tion and orientation of the human arm which is mapped 
to a virtual dummy arm on a graphical display that pres-
ents the actual task to the patient. A randomized con-
trolled clinical trial  [28] demonstrated that exercising
the affected arm of 14-month chronic-stroke survivors 
 Fig. 1. The end-effector-based robot (left) is connected to the hu-
man hand only. The exoskeleton robot (right) is connected to the 
upper arm, the lower arm and hand.  
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using T-WREX for 24 h for an 8-week period improved 
unassisted movement ability – mean change in the Fugl-
Meyer Assessment (FMA) score was 3.6 points  8 3.9 
(mean  8 SD). 
 Compared to motorized robots, nonmotorized devic-
es are intrinsically safer, easier to manipulate and handle, 
and less expensive  [29] . Due to their lower inertia, non-
motorized devices are better suited to train very fast or 
ballistic movements. One obvious disadvantage is that 
these devices support the human limb against gravity 
only. This means that directed movements toward an ob-
ject and joint movements such as elbow extensions and 
others cannot be assisted by the devices. Most motorized 
devices can simulate passive behavior, increase the level 
of difficulty by providing resistance against a user-driven 
motion and assist the patient in his or her movement. 
Since severely affected patients need a lot of assistance 
and well-functioning patients might benefit from resis-
tance, we expect that the effects of training with motor-
ized devices will be superior to training with nonmotor-
ized devices. 
 This is a pilot study to test the feasibility of using the 
ARMin I robot as a rehabilitation tool for improving arm 
function in chronic-stroke victims. The specific hypoth-
eses that are tested in this study are: (1) intensive arm 
training with the arm exoskeleton ARMin I is feasible 
with chronic-stroke patients and (2) repetitive and inten-
sive arm training with ARMin I for a 2-month period will 
improve the motor performance of the affected arm as 
expressed by the FMA score  [26] . 
 Participants and Methods 
 Participants 
 The study was approved by the local ethics review board. Only 
chronic-stroke patients were included in order to minimize side 
effects from spontaneous recovery. Patients were  included  in this 
study if they fulfilled all of the following criteria: 18–70 years of 
age, with a first-ever ischemic stroke that occurred at least 12 
months prior to the study, termination of conventional therapy 
and stable recovery stage (outpatients) with moderate to severe 
motor impairment of the arm (upper limb portion of the FMA 
score between 10 and 38), able to sit in a chair without any addi-
tional support, and written informed consent. Patients were  ex-
cluded from this study if they fulfilled one of the following crite-
ria: excessive spasticity of the affected arm (modified Ashworth 
Scale  1 4); any serious medical or psychiatric illness; participation 
in any clinical investigation within 4 weeks prior to the start of 
this study; an anticipated need for major surgery during the study; 
women known to be pregnant or lactating; orthopedic, rheuma-
tologic, or other disease that restricts movements of the paralyzed 
upper extremity; shoulder subluxation (palpatory  1 2 fingers); 
diseased or damaged skin at the paralyzed arm; inability to com-
municate effectively with the neurological examiner; serious cog-
nitive deficits (Mini Mental State Exam score  ^  21); aphasia pre-
venting the performance of the ARMin treatment, or participa-
tion in any treatment performed with the paralyzed arm during 
the planned study.
 Based on the inclusion/exclusion criteria, 3 patients were se-
lected. On admission, subject 1 was 48 years old, 14 months after 
stroke. Subject 2 was 65 years old, 40 months after stroke. Subject 
3 was 55 years old and 25 months after stroke ( table 1 ). 
 Study Design 
 To investigate possible effects of intensive training with the 
ARMin I device, 3 single-case studies with an A-B design and 
multiple baseline measurements were performed. During the 
baseline phase (A), the functional state of the subjects’ impaired 
upper extremity was recorded 3–4 times within 2 weeks with sev-
eral measurements (see below). In the subsequent intervention 
phase (B), intensive arm trainings were performed for 8 weeks. 
Whereas subjects 1 and 2 received three 1-hour training sessions 
per week, subject 3 received five 1-hour training sessions per 
week. Subject 3 had more training sessions per week to investigate 
whether this single subject will tolerate the increased dosage. 
Eight weeks after the end of the intervention phase, follow-up 
measurements were recorded. 
 Training Sessions 
 This study was performed with the ARMin I robot  [14] . The 
device stimulates three senses:  haptics which is stimulated by the 
physical interaction between the robot and the human,  vision by 
a graphical animation that is presented on a computer monitor in 
front of the patient, and  hearing stimulated by sounds from two 
loudspeakers. The device has an exoskeleton structure that con-
nects to the affected upper arm, the lower arm, and the hand. The 
robot has four motors to provide shoulder abduction/adduction, 
shoulder flexion/extension, internal/external shoulder rotation, 
and elbow flexion/extension. It is equipped with sensors that 
measure position and interaction torques between the human 
arm and the robot. This allows the device to work either in robot-
driven (passive mobilization) or patient-driven (patient active) 
control mode. As shown in  figure 2 , the patient sits in a wheel-
chair and looks at a computer monitor. Depending on the training 
mode, the monitor shows one of two graphical animations 
( fig. 2 ).
 Note that the motor for internal/external shoulder rotation 
was blocked for this first clinical study and there was no actuation 
of distal joints. Due to these limitations, it was not possible to 
train task-oriented movements as suggested before. Therefore, 
simplified movements with 3 degrees of freedom (DOF) were 
trained. However, based on the experience with the ARMin I de-
vice, future versions will be equipped with more DOF and will 
allow the suggested training of ADL tasks. 
 Every 1-hour training session started with 20–30 min of  pas-
sive mobilization . To allow the therapist to select a patient-spe-
cific mobilization movement, a teach-and-repeat procedure was 
used. The therapist first guided the arm together with the robot, 
while the robot recorded the movement (‘teach’). Then, the same 
movement was repeated by the robot several times (‘repeat’). Dur-
ing the teaching procedure, the robot was controlled in a zero 
impedance (zero resistance) mode; thus, the motors were used to 
compensate for the robot’s weight and the joint friction so that the 
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therapist mainly felt only the weight and the resistance of the hu-
man arm. Additional visual feedback about the actual position 
and orientation of the affected arm was provided to the patient via 
the computer monitor ( fig. 2 ) showing a dummy arm that reflects 
the position and orientation of the real arm. During passive mo-
bilization, the subjects were instructed to watch the graphi-
cal animation. The mobilization pattern included all 3 available 
DOF, thus shoulder abduction/adduction, shoulder flexion/ex-
tension, and elbow flexion/extension.
 The remaining time of the 1-hour training session was dedi-
cated to  active training . Subjects tried to catch a ball rolling down 
a ramp at different locations. The ball was captured and reflected 
by a handle displayed on the screen. Every capture was accompa-
nied by a sound and after 8 consecutive reflections, a new ball was 
launched. The position of the handle was controlled by shoulder 
and elbow movements. According to the patient’s needs, the ther-
apist could select 1 out of 4 different modes ( table 2 ).
 In modes 3 and 4, vertical motion of the handle was provided, 
and subjects could accelerate the ball by hitting it strongly, which 
added an additional challenge to the training. According to the 
patient’s need, the therapist could vary the level of weight com-
pensation of the arm from 0 to 100%. 
 During the active training, the robot worked in the user-driv-
en (patient-active) mode (robot impedance controlled). The robot 
was programmed so that if the subject caught the ball, the robot 
provided no assistance. Only if the subject was unable to catch the 
ball would the robot support the patient with an adjustable force 
and push him or her toward the ball  [14] . Since the patients were 
only supported if they could not catch the ball, the amount of ro-
bot support decreased as the patient improved his or her perfor-
Table 1. Data of the subjects on admission
 Subject 1 Subject 2 Subject 3
Gender male male female
Age 48 65 55
Handedness (before stroke) right right right
Hemisphere of unilateral stroke right right left
Months after stroke (on admission) 14 40 25
Reflex activity1 hyperactive hyperactive hyperactive
Sensation1 reduced reduced reduced
Neglect1 slight slight slight
BI2 (0–100) 90 85 90
Mini Mental score3 (0–30) 29 28 22
FMA(0–66) 14 26 15
Muscle tone1 (Ashworth Scale)4 (0–5)
Pure shoulder flexion and abduction 2 2 1
Elbow flexion 2 2 2
Elbow extension 4 4 4
Wrist extension 4 4 3
Finger extension 4 3 3
Muscle strength1 (MRC)5 (0–5)
Shoulder abduction 2 3 2
Pure shoulder flexion 2 3 2
Transversal shoulder ab-/adduction 4 4 4
Elbow flexion S6 4 4
Elbow extension S6 4 2
Active range of motion1
Impairment in shoulder severe moderate severe
Impairment in elbow moderate slight moderate
1 On the impaired side of the body.
2 BI: 0 = total need for care, 100 = completely independent.
3 Mini Mental score: 0 = severe dementia, 30 = no dementia.
4 Ashworth Scale: 0 = no spasticity, 5 = severe spasticity.
5 MRC = Medical Research Council: 0 = no muscle contraction, 5 = full strength.
6 S stands for spasticity. It was noted when a muscle or a muscle group was too spastic to enable determina-
tion of strength.
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mance during the training. To give the subject visual feedback of 
his or her performance, the color of the handle turned from green 
to red whenever robot support was delivered. 
 During the first 3 weeks of the intervention phase, subject 1 
spent half of the active training time of each session in training 
modes 1 and 2. In weeks 4–8, half of the active training time was 
dedicated to training mode 3 and the other half to training mode 
4. The weight compensation of the arm was reduced in a stepwise 
manner. Subjects 2 and 3 spent about one third of the active train-
ing time in training mode 1 and two thirds of their time in train-
ing mode 4. The weight compensation of the arm was also reduced 
stepwise.
 Outcome Measurements and Data Analysis 
 The motor performance of the affected arm was assessed 3 
times during the 2-week baseline phase, 9 equally distributed 
times during the 8-week intervention and once for the 8-week fol-
low-up. It included measurements of function, coordination, 
range of motion and strength.
 The primary outcome measurement was the upper-limb por-
tion of the FMA  [30] . In addition to the FMA, to assess the sub-
jects’ ability to cope with ADL, the Barthel Index (BI) was used 
 [31] . Furthermore, hand function was assessed by the Action Re-
search Arm Test (ARAT)  [32] , a series of 19 tasks covering grasp, 
grip, pinch, and gross arm movements.
 The subject’s ability to coordinate his or her movements was 
assessed by a standardized version of the active training that in-
cluded catching balls that were presented from different locations 
in a randomized order. The subjects were instructed to match the 
handle’s center mark with the ball reflection point. During this 
measurement, the robot’s support was turned off and the distance 
between the center mark and the ball reflection point was mea-
sured and recorded. 
 The active range of motion (AROM) in transversal shoulder 
abduction and elbow flexion and extension was recorded with 
ARMin. In the starting position, the shoulder was flexed to 70° 
and transversally abducted to 20°, the rotation was neutral, and 
the elbow was flexed to 50°. The AROM in shoulder flexion and 
shoulder abduction was determined using manual goniometry. 
The strength, i.e. the maximal voluntary muscle torques (MVTs) 
generated by isometric muscle contraction, was also determined 
using ARMin. The position (isometric) was the same as for the 
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 Fig. 2. Healthy subject sitting in a wheelchair with one arm con-
nected to the ARMin I exoskeleton. The exoskeleton is connected 
to the human limb via the upper arm cuff (1), the wrist cuff (2), 
and the hand support (3). The linear drive (4) and the motor (5) 
power shoulder motion and the motor (6) powers elbow flexion/
extension. The motor (7) drives internal/external shoulder rota-
tion and has been disabled for the training. The computer monitor 
shows screen (8) during the passive mobilization and screen (9) 
when working in the active training mode. For the sake of clarity, 
the photo does not show an additional passive linkage that has 
been used to stabilize the shoulder actuation of the exoskeleton 
 [14] .  
Table 2. Control modes for the active training
Elbow flexion/extension Transversal shoulder motion Shoulder flexion/extension
Mode 1 controls horizontal handle position blocked blocked
Mode 2 blocked controls horizontal handle position blocked
Mode 3 controls horizontal handle position blocked controls vertical handle position
Mode 4 blocked controls horizontal handle position controls vertical handle position
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AROM measurement. The tested muscle groups included those 
responsible for shoulder flexion/abduction (due to the 20° of 
transversal shoulder abduction in the starting position, both 
muscle groups were involved), shoulder extension/abduction and 
transversal shoulder ab- and adduction. The subjects were in-
structed to maintain their maximal torque for at least 2 s.
 To ensure testing consistency, all measurements were execut-
ed by the same researcher. 
 The FMA, AROM and strength measurements were always 
taken before training. Thus, the measuring conditions were the 
same during baseline and the intervention phase. To diminish the 
influence of the learning effect due to the repetitive accomplish-
ment of the measurements, the participants completed two test 
measurements on different days before onset of the baseline 
phase. The coordination test was performed after mobilization. 
Since no mobilization occurred during the baseline phase, the 
data of the coordination test were collected during the interven-
tion phase only.
 The statistical analysis of the FMA, BI, ARAT, AROM and 
strength data recorded during the baseline phase included the 
calculation of the means and the standard deviation (SD) of the 
means. For all data recorded during the intervention phase, linear 
regression including the standard error (SE) and the p value of the 
slope of the regression line were calculated. Furthermore, it was 
analyzed whether the endpoint of the regression line (EPR) was 
higher than the mean of the baseline data +2 SDs. The linear mod-
el of regression was applied because it provides an easy way of 
quantifying improvements. To interpret the statistical data, slopes 
of regression lines with a p value of  ^  0.2 were assumed to indicate 
an increasing/decreasing tendency. If the p value was  ^  0.05, the 
increase/decrease was considered statistically significant. 
 Results 
 The FMA of all 3 subjects showed significant improve-
ments ( fig. 3 ). The gains in subjects 1, 2, and 3 were 3.1, 
3.0, and 4.2 points, respectively. In percentages of the to-
tal score (66 points), the increases were 4.7, 4.6 and 6.4%, 
respectively. Follow-up measurements showed that sub-
ject 1 could maintain the increased level, subject 3 could 
maintain it to some degree, and subject 2 returned to the 
baseline level. The ARAT and the BI did not change in 
any subject ( table 3 ). 
 All 3 subjects showed improved performance on the 
coordination test ( table 3 ). Regarding the shoulder move-
ments, subjects 1 and 2 showed statistically significant 
improvements (p  ^  0.05) and subject 3 showed a ten-
dency to improve (p  ^  0.2). Regarding the elbow move-
ments, subjects 1 and 3 showed an improving tendency 
and subject 2 showed significant improvements. In both 
shoulder and elbow, the improvements were maintained 
to some degree 8 weeks after the end of the intervention 
phase ( table 3 ).
 Overall, all 3 subjects showed increased AROMs. Re-
garding transversal shoulder abduction, the EPR was 
higher than the mean  8 2 SDs in subjects 2 and 3. The 
increases were 13.7 and 19.3°, respectively. In subject 1, 
only one baseline value was available, and therefore, the 
increase from the mean of the baseline to the EPR could 
not be determined. All subjects could maintain the in-
creased level until follow-up measurements. The im-
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 Fig. 3. FMA scores of subjects 1–3. For every subject, at least 3 baseline values ( y ), 8 values during intervention 
( I ) and 1 follow-up value are available ( N ). The solid lines represent the linear regression lines of the data record-
ed during the intervention phase, and the dotted lines denote the means of the baseline values  8 2 SDs. 
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provement in AROM in shoulder abduction was less 
than  8 2 SDs of baseline. Subjects 1 and 3 were unable to 
perform a shoulder flexion without abduction. There-
fore, the AROM in shoulder flexion could be determined 
only in subject 2. These data did not change during the 
course of the study. Regarding elbow flexion/extension, 
the data showed a statistically significant increase and 
the EPRs were higher than the mean  8 2 SDs in subjects 
1 and 3. The increases were 31.7 and 22.5°, respectively, 
but subject 2 also showed a nonsignificant increase of 
9.5°. At follow-up, all subjects maintained the increased 
level.
 In general, all 3 subjects showed increased MVTs. In 
shoulder flexion, a statistically significant increase was 
observed in subject 3 and the EPR was higher than the 
mean  8 2 SDs ( fig. 4 ). The increase was 23.7 Nm (123%) 
and was maintained until follow-up. In shoulder exten-
sion, the data of subjects 1 and 2 showed a statistically 
significant increase. However, as the starting point of the 
regression line was considerably lower than the mean of 
the baseline, the EPRs were not higher than the means 
 8 2 SDs. The values achieved by the end of the interven-
tion phase were maintained until follow-up. The MVTs 
in transversal shoulder abduction did not increase in 
subjects 1 and 2. In contrast, in subject 3, there was a sta-
tistically significant increase and the EPR was higher 
than the mean  8 2 SDs. The increase was 12.8 Nm 
(133%). Only a small portion of this increase could be 
maintained until follow-up. In transversal shoulder ad-
duction, the data of subjects 1 and 2 tended to increase. 
Although the improvements were not statistically signif-
icant, the EPRs were higher than the means  8 2 SDs. 
The increases were 10.1 (126%) and 11.4 Nm (120%). 
These increased levels were also reached on the follow-
up examinations. 
 Discussion 
 Results of the ARMin I Study 
 It is well known that coordination of muscle activation 
in stroke is impaired due to brain lesions  [33–35] . One 
consequence is the loss of dexterity  [36] . Moreover, the 
number of motor units activated is often decreased  [37] 
and pronounced cocontraction of agonistic and antago-
nistic muscles can appear  [38] . Both these consequences 
seem to cause muscle weakness in stroke patients. Since 
intensive training has been shown to induce changes in 
cortical activation, even in chronic-stroke patients  [6, 38] , 
ARMin I training was expected to improve coordination 
of muscle activation. In turn, improvements in coordina-
tion of muscle activation were expected to align with im-
provements in muscle strength. 
 The AROM and the FMA were assumed to increase in 
parallel. Since others have reported that the BI is incon-
sistent in clinical trials in stroke medicine  [39] , no expec-
tations about changes were made. This is also the case for 
the ARAT score, which exclusively tests hand function. 
Table 3. Summary of the results
Subject 1
baseline
mean 8 SD
regression line follow-
upslope 8 SE end point p
Coordination transversal ab-/adduction NA –0.1280.04 0.6 0.03 0.7
Coordination elbow flexion/extension NA –0.3480.16 0.6 0.09 1.3
Strength shoulder flexion/abduction, Nm 32.9811.5 0.0280.75 36.3 0.98 46.0
Strength shoulder extension/adduction, Nm 40.986.4 2.6481.08 45.8 0.05 42.7
Strength transversal abduction, Nm 14.883.9 0.0980.27 17.9 0.76 11.1
Strength transversal adduction, Nm 8.082.1 0.7580.38 18.1 0.09 18.1
AROM shoulder abduction, degrees 51.3811.0 1.2380.71 62.0 0.13 60.0
AROM shoulder flexion, degrees NA NA NA NA NA
AROM transversal abduction, degrees NA 2.5681.81 62.4 0.21 69.4
AROM elbow flexion/extension, degrees 71.380.7 5.5381.33 103.0 <0.01 91.8
FMA (0–66) 13.380.6 0.3580.11 16.4 0.02 17.0
ARAT (0–57) 4.080.0 0.0480.04 4.00 0.44 4.00
BI (0–100) 90.080.0 0.0080.00 90.00 90.00
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Since hand function was not trained in this trial, no 
changes were expected. 
 As expected, subject 1 showed improvements in the 
coordination test (shoulder and elbow movements) as 
well as in muscle strength and AROM. An increase in 
the FMA score was achieved in two tasks of which only 
one was trained. Therefore, a transfer process may have 
taken place. In subject 2, the ARMin I training mainly 
influenced the coordination of shoulder and elbow 
movements. An improvement in AROM only occurred 
in transversal shoulder abduction, and this improve-
ment occurred only in the first training week. One pos-
sible explanation for this restriction is that the value 
reached after the first training week corresponded to 
the maximum angle of the training settings. The in-
crease in the FMA score can mainly be ascribed to the 
improved ability to purely flex and abduct the shoulder 
without flexion of the elbow. This finding indicates a 
slightly reduced dependence on the synergy patterns 
that are characteristic of stroke patients  [40] . In subject 
3, improvements were most pronounced. The reason 
seems to be twofold: this subject had a greater number 
of training sessions and had a left-hemispheric lesion 
which is reported to be advantageous for training re-
sponse in right-handed subjects  [34] . Improvements in 
the FMA score can be correlated to improved shoulder 
abduction (as part of a complex movement), shoulder 
flexion and abduction without flexion of the elbow as 
well as improved ability to put the hand onto the lumbar 
spine. The improvements in shoulder flexion and ab-
duction without flexion of the elbow suggest that, as in 
subject 2, the dependence on synergy patterns might 
have been reduced. This matches the findings of Ellis et 
al.  [41] , who reported that abnormal joint patterns can 
be reduced by training. 
 The relevance of these results to other attempts at au-
tomating movement training after stroke will be dis-
cussed first, and then directions for future research will 
be addressed. Since the FMA score is the main outcome 
measurement of most studies, including the ARMin I 
study, the comparison with other studies is based on the 
FMA only. 
 Comparison with Other Robot-Supported Arm 
Therapy Studies  
 In a randomized, blinded and controlled trial includ-
ing 27 chronic-stroke patients (6 months after stroke), 
robotic therapy with the end-effector-based robot 
MIME was compared to conventional neurodevelop-
mental therapy targeting proximal upper limb function 
 [21] . Both groups received 24 therapy sessions of 1 h 
each for 2 months. At the end of the intervention, the 
gains in the FMA scores were 4.7  8 1.2 points in the 
robot group versus 3.1  8 0.8 points in the control group. 
At the same point in time, in the ARMin I study, gains 
in the FMA score were 3.1, 3.0 and 4.2 points for subjects 
1, 2 and 3. 
Subject 2 Subject 3
baseline
mean 8 SD
regression line follow-
up
baseline
mean 8 SD
regression line follow-
upslope 8 SE end point p slope 8 SE end point p
NA –42.080.06 0.7 <0.01 1.4 NA –0.1380.07 1.3 0.10 1.0
NA –0.4080.13 1.0 0.03 2.3 NA –0.5880.41 3.7 0.21 3.2
52.083.0 1.4481.27 56.6 0.30 60.0 19.383.8 2.8080.76 43.0 <0.01 39.8
41.085.1 2.9080.67 51.2 <0.01 49.2 23.586.6 –0.4881.13 29.3 0.68 40.7
19.081.6 0.4580.48 19.3 0.38 19.7 9.682.3 0.8980.17 22.4 <0.01 16.9
9.582.5 0.8180.47 20.9 0.14 20.2 1.982.7 –0.1080.29 2.2 0.73 7.4
95.086.4 1.3981.05 98.8 0.24 100.0 66.0810.5 0.2481.64 76.5 0.89 80.0
101.083.5 0.4681.11 103.0 0.69 100.0 NA NA NA NA NA
67.786.0 0.5080.44 81.4 0.30 85.9 79.283.1 1.4780.83 98.5 0.12 98.5
75.086.3 1.0880.79 84.5 0.23 91.9 78.086.3 1.7780.28 100.5 <0.01 99.8
30.080.0 0.2980.07 33.0 <0.01 30.0 17.080.0 0.4680.13 21.2 <0.01 18.0
13.080.8 0.0480.25 14.00 0.88 12.00 4.580.6 0.1180.09 4.80 0.23 4.0
85.080.0 0.0080.00 85.00 85.00 90.080.0 0.0080.00 90.00 90.00
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
7/
1/
20
16
 2
:4
5:
18
 P
M
 Nef /Quinter /Müller /Riener Neurodegenerative Dis 2009;6:240–251248
 In the ARMin I study, subjects 1 and 2 received 24 
therapy sessions of 1 h each for 2 months, and subject 3 
received 32 therapy sessions of 1 h each for the same du-
ration. Therefore, the beneficial effects of the ARMin I 
therapy in this study were less pronounced than those in 
the MIME study. In fact, the effects of the ARMin I study 
were very similar to those of the control groups of the 
MIME study. Note that the protocol of the robotic group 
in the MIME study included a bimanual mode. In this 
mode, the two forearms were kept in mirror symmetry 
by a position digitizer that measured the movement of the 
contralateral forearm and provided coordination for the 
robot motion controller of the affected arm. This mode 
might explain the higher gains in the MIME study. 
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 Fig. 4. MVT in shoulder flexion of subjects 1–3. The circles ( y ) refer to baseline measurements, the dots ( I ) 
represent data that were recorded during the intervention phase, and the stars ( N ) represent data from follow-
up measurements. The solid lines represent the linear regression lines of the data recorded during the interven-
tion phase, and the dotted lines denote the means of the baseline values  8 2 SDs. 
 Fig. 5. AROM in the elbow flexion/extension of subjects 1–3. The circles ( y ) refer to baseline measurements, 
the dots ( I ) represent data that were recorded during the intervention phase, and the stars ( N ) represent data 
from follow-up measurements. The solid lines represent the linear regression lines of the data recorded during 
the intervention phase, and the dotted lines denote the means of the baseline values  8 2 SDs. 
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 The improvements observed in the ARMin I study are 
also comparable to improvements with other end-effec-
tor-based devices such as the MIT-MANUS (4.2 addi-
tional points on the FMA with the robot therapy)  [42] 
and the GENTLE/s (4-point gain on the FMA with the 
robot therapy)  [43] . 
 A randomized controlled clinical trial  [44] with the 
passive, nonrobotic exoskeleton T-WREX has been car-
ried out with 23 chronic-stroke patients. Subjects with 
moderate to severe upper-limb hemiparesis were trained 
3 times a week for 8 weeks with minimal supervision by 
occupational therapists. In preliminary results, the T-
WREX group demonstrated significant improvements
in arm movement (3.7 points mean improvement on the 
FMA, p = 0.001). An important secondary finding of this 
study was that the training with the arm exoskeleton led 
to significant gains in self-rated quality of arm move-
ments on the Motor Activity Log (p = 0.05). 
 Interpretation and Directions for Future Research 
 This study has aimed to test whether intensive arm 
training with the arm exoskeleton ARMin I is feasible 
with chronic-stroke patients (hypothesis 1) and to test 
whether repetitive and intensive arm training with the 
ARMin I for a 2-month period will improve motor per-
formance in the affected arm as measured by the FMA 
score (hypothesis 2). The training was feasible and very 
much appreciated by the patients. Thus, hypothesis 1 is 
confirmed by this study. In effect, not a single training 
session was canceled. Two different dosages were tested: 
3 h a week and 5 h a week. Both were well tolerated, and 
we will continue to deliver these dosages in future stud-
ies. The 3 single cases had considerable spasticity, and we 
observed that the selected training paradigm, starting 
with 20–30 min passive mobilization, followed by active 
training, was well suited to these patients. In effect, we 
observed that passive mobilization seems to reduce spas-
ticity and improve flexibility. These effects will be further 
investigated in future clinical trials.
 Significant improvements in the FMA scores were 
found in all patients, which is in support of hypothesis 2. 
Three subjects are not sufficient to definitively prove hy-
pothesis 2, but the data obtained in this study justify a 
larger-scale randomized clinical trial.
 Overall, the mean improvement in the FMA scores in 
this study (3.4 points) compares well with the results of 
studies with end-effector-based robots. The study with 
the MIME robot, in which the mean gains on the FMA 
where higher (4.7 points), was the only exception. How-
ever, we expected that the effects of training with mo-
torized exoskeletons would be superior to training with 
end-effector-based devices because we believed that exo-
skeletons were better suited for training task-oriented 
movements. Since only 3 of the DOF of the ARMin I de-
vice were used and ADL movements require at least 6 
DOF plus hand-opening and closing  [18] , the training 
procedure in this study did not include task-oriented 
movements. It is, therefore, no surprise that changes in 
the FMA score are rather small. This is also the reason 
why the second version of the device, the ARMin II robot, 
is equipped with 6 DOF, which allow training of task-re-
lated movements  [45] . 
 The mean gain on the FMA in the T-WREX study (3.7 
points) was slightly higher than the mean gain in the
ARMin study (3.4 points). The main advantage of the
T-WREX is that the device provides movements with 5 
DOF plus hand actuation; this enables the training of 
tasks that are very close to ADL tasks. The ARMin II ro-
bot will be able to provide similar exercises with addi-
tional motorized support.
 Conclusion 
 This study examined the effects of intensive arm ther-
apy with the ARMin I robotic device. While most studies 
on the influence of robotic training have been conduct-
ed with end-effector-based robots, the present study has 
been carried out with an actuated exoskeleton robot. 
Thanks to a large ROM and enhanced joint guidance, the 
exoskeleton structure enables the training of ADL-relat-
ed, task-oriented movements. A simplified version of 
ARMin with only 3 DOF has been used. Due to the lim-
ited number of DOF, only nonfunctional movements 
could be trained in this study. Nevertheless, the ARMin 
I served as model for the ARMin II robot, which has 6 
DOF and allows ADL training. We expect more pro-
nounced improvements in subjects that undergo ARMin 
II training. 
 The present study on 3 single cases has shown that 
the ARMin I training had positive effects on the coor-
dination of arm movements, functional tasks, AROM, 
and muscle strength. Most improvements could be 
maintained 8 weeks after the end of the intervention 
phase. However, individual subjects did not improve in 
all parameters and the parameters that did improve dif-
fered widely. Therefore, the effects of the ARMin I train-
ing seem to be individual and differ among the 3 sub-
jects. 
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 The fact that the improvements did not occur in all 
movements trained is consistent with the results reported 
by others. The improvements in the FMA scores are sim-
ilar to those in studies with end-effector-based robots 
and passive, nonrobotic exoskeletons. This was the first 
study on the ARMin I exoskeleton; future studies will be 
performed with improved versions of the ARMin device 
and are expected to show better results.
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